Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.07591 | 67 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.95 | 66 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.07456 | 67 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.05526 | 67 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.8681 | 74 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.10077 | 67 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.07223 | 66 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.05988 | 67 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.25425 | 69 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.07233 | 67 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.06082 | 67 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.03031 | 67 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.07771 | 67 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.06224 | 67 |